Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells-Reference-Cited by-同舟云学术

Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells

Published:2018-08-21 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lei Kefeng,Sun Ran,Chen Lee H.,Diplas Bill H.^ORCID,Moure Casey J.,Wang Wenzhe^ORCID,Hansen Landon J.,Tao Yulei,Chen Xufeng,Chen Chin-Pu Jason,Greer Paula K.,Zhao Fangping,Yan Hai,Bigner Darell D.,Huang Jiaoti,He Yiping

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-30062-z.pdf

Reference42 articles.

1. Bielas, J. H., Loeb, K. R., Rubin, B. P., True, L. D. & Loeb, L. A. Human cancers express a mutator phenotype. Proceedings of the National Academy of Sciences of the United States of America 103, 18238–18242, https://doi.org/10.1073/pnas.0607057103 (2006).

2. Bielas, J. H. & Loeb, L. A. Quantification of random genomic mutations. Nature methods 2, 285–290, https://doi.org/10.1038/nmeth751 (2005).

3. Araten, D. J. et al. A quantitative measurement of the human somatic mutation rate. Cancer research 65, 8111–8117, https://doi.org/10.1158/0008-5472.CAN-04-1198 (2005).

4. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558, https://doi.org/10.1126/science.1235122 (2013).

5. Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science signaling 6, pl1, https://doi.org/10.1126/scisignal.2004088 (2013).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy;Cancer Letters;2022-05

2. Immune-Related Genes Are Prognostic Markers for Prostate Cancer Recurrence;Frontiers in Genetics;2021-08-19

3. Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications;Medicines;2019-07-30

4. Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3;Epigenetics;2019-06-28

5. Predicting clinical outcome of therapy-resistant prostate cancer;Proceedings of the National Academy of Sciences;2019-05-21